Researchers at the University of California-Davis report that glasses fitted with a miniature camera that uses optical character-recognition technology could help people who qualify as legally blind to read again.
Interventional oncology specialist BTG is working to make med tech more relevant in oncology--something it's got a shot at doing as localized treatment delivery and minimally invasive surgical techniques continue to emerge.
Taiwan's ACT Genomics roped in $12.5 million in Series B funding to spur development of its cancer tests and to chart growth in Asia's fast-growing diagnostics market.
Royal Philips has installed the first spectral detector-based computed tomography (CT) system at the University Medical Center Utrecht.
AliveCor brought on a former Google exec last year to run the company. Now, it may be on the path to the data it needs to make its smartphone-based ECG recorder the standard-of-care for patients with undiagnosed heart palpitations.
B. Braun Medical has recalled a hemodialysis system to treat chronic kidney disease patients that could allow air to enter the dialysis solution. This could lead to improper blood filtration as well as other consequences including death--so the FDA has now given the recall its most serious designation of Class I.
Houston, TX-based startup OrthoAccel Technologies has raised a $12 million Series C financing to back its FDA-cleared device that's intended to cut the time for orthodontic treatment by up to 50% and to relieve patient discomfort.
Apple has been taking a deeper dive into med tech, and now, it's bringing on new talent to give its efforts a boost. The company is hiring a former Google exec and robotics expert to lead some of its healthcare initiatives on the iPhone.
Valeritas has done a reverse merger to get a public listing and raised $25.2 million after spiking a proposed IPO earlier this year. It's just the latest med tech to take the reverse merger route lately--implantable glucose sensor company Senseonics did one late last year--as the IPO market remains almost entirely closed to med techs.
IBM and Bausch + Lomb are teaming up to develop a new app to help surgeons perform cataract surgeries. The move comes as IBM strikes more deals with life sciences and med tech companies to expand its market reach.
Dx Digest: Foundation Medicine expands companion Dx deal with AstraZeneca; Seegene sets sail to Mexico
In this week's Dx Digest, Foundation Medicine inked a companion diagnostics deal with AstraZeneca and launched its liquid biopsy test, Seegene expanded its global presence with a new joint venture in Mexico, and Germany's Epigenomics got a pat on the back from Chinese regulators for its colorectal cancer test.
Medtronic has added Karen Parkhill as EVP and CFO. She was previously with financial services firm Comerica, where she was vice-chair and CFO for 5 years.
Abbott Laboratories is seeking a new path to growth--and it's betting big that med tech is it. The company is taking on two of the largest M&A transactions in history at the same time: the more than $5.8 billion purchase of diagnostics player Alere that it announced at the start of February and the more than $25 billion buy of cardiovascular device player St. Jude Medical that was disclosed in late April.
Siemens has rebranded and will expand its Healthcare business. The imaging and laboratory diagnostics giant has, perhaps a bit awkwardly, rebranded the business as Siemens Healthineers. The group is a separately managed business within the larger corporate structure, a transition that happened early last year.
Greatbatch and wireless power company WiTricity like working together so much, they're sweetening the deal. The companies struck an expanded agreement to bring WiTricity's wireless tech to a greater number of medical devices and systems.
Symmetry Surgical, a global marketer and distributor of surgical devices, has agreed to be acquired for $140.3 million by healthcare-focused private equity firm Roundtable Healthcare Partners.
A lot of fingers have been pointed during Theranos' fall from grace, with most of them directed at the company and its beleaguered front woman Elizabeth Holmes. But now, a new report is placing some of the blame on new shoulders: the Silicon Valley press.
MVM Life Science Partners has closed a $233 million fourth fund to invest in technologies, therapeutics, medical devices and healthcare IT companies.
Perhaps not too surprisingly, medical device megagiant Medtronic has again bested tiny Tandem Diabetes Care in the continuous glucose monitor market. Tandem disclosed that its customer UnitedHealthcare would adopt Medtronic as its in-network insulin pump provider.
Following allegations aired on CBS' 60 Minutes Sunday that Halyard Health for years deliberately marketed substandard healthcare equipment, the medical device and equipment company struck back on Monday with a denial.